ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Joshua Sharlin, Ph.D. Launches New Shareholder Lawsuit Expert Witness Service

Joshua Sharlin, Ph.D., has launched a new Shareholder Lawsuit Expert Witness service. Leveraging decades of FDA, regulatory, and product development expertise, Dr. Sharlin provides expert support in cases alleging that a company’s FDA-related actions or decisions contributed to a preventable loss in shareholder value.

-- Joshua Sharlin, Ph.D. founder of Sharlin Consulting, has now launched a range of shareholder lawsuit expert witness services for attorneys, bringing experience with the entire lifecycle of product development. Dr. Sharlin also brings a wide range of expertise involving pharmaceuticals, biologics, and medical devices, and has served as an FDA regulatory expert witness and consultant in a wide range of legal matters.

Dr. Sharlin now offers his expertise in cases involving allegations that a company’s FDA-related actions or decisions led to an avoidable decline in shareholder value. He brings hands-on work throughout the entire life cycle of product development, from early development of a regulatory strategy, clinical trial planning and execution through regulatory submission and post-market safety surveillance. His track record includes writing expert reports, being deposed, (20+ times) and testifying (5 times) in court and arbitration, with no opinions excluded under the Daubert challenge.

Bringing over a decade of expert witness engagement experience, Dr. Sharlin supports attorneys in a wide range of high-stakes cases, including:

  • Wrongful death or serious injury
  • Patent and trade secret litigation
  • Insurance disputes tied to FDA labeling or compliance
  • Contract and M&A disputes involving regulatory obligations
  • Stock fraud involving FDA-regulations and compliance
  • Off-label promotion, data integrity violations, and criminal charges

Having worked as an FDA drug reviewer, Ph.D.-level biologist, and seasoned industry consultant, Dr. Sharlin is able to provide clear, courtroom-ready analyses of product lifecycles, including FDA submissions, clinical data, and software integrity. With experience in more than 50 litigation matters, he brings the ability to translate complex technical and regulatory issues into clear, persuasive insights and to apply that expertise to expert reports and testimony.

With his new shareholder lawsuit expert witness services, Dr. Sharlin aims to help attorneys in cases when a company’s failure to follow required regulatory steps, misrepresentation of product or process integrity, or deficient oversight is alleged to have contributed to a significant decline in stock price. His knowledge in the field allows Dr. Sharlin to analyze how and when failures in judgement or process occurred, and how they could have and should have been avoided.

Attorneys who require independent, experience-backed expert opinions on shareholder issues are encouraged to visit his website to learn more about how Dr. Sharlin can support their litigation strategy and strengthen their cases.

For more information about Sharlin Consulting, LLC., use the contact details below:

Contact Info:
Name: Joshua Sharlin, Ph.D.
Email: Send Email
Organization: Sharlin Consulting, LLC.
Phone: (410) 231-8900
Website: https://sharlinconsulting.com/

Release ID: 89173361

Should there be any problems, inaccuracies, or doubts arising from the content provided in this press release that require attention or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is central to our commitment.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.25
+2.28 (1.00%)
AAPL  269.00
+0.19 (0.07%)
AMD  258.01
-1.66 (-0.64%)
BAC  52.87
-0.15 (-0.28%)
GOOG  268.43
-1.50 (-0.56%)
META  751.44
+0.62 (0.08%)
MSFT  542.07
+10.55 (1.98%)
NVDA  201.03
+9.54 (4.98%)
ORCL  280.83
-0.57 (-0.20%)
TSLA  460.55
+8.13 (1.80%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.